The Valley Desk

NCT06072183 · Interventional trial

A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2

Overall registry status Active not recruiting

Phase 3

Conditions Active Nonsegmental Vitiligo, Stable Nonsegmental Vitiligo

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov